Biophotonic Therapy is the use of light to activate the healing properties of the blood. BT is photomedicine and has a well-characterized clinical profile. A dozen books and some 400 articles in the medical literature describe Biophotonic Therapy. Other common names for BT are Ultraviolet Blood Irradiation and Photoluminescence Therapy.
In BT’s extracorporeal form, ultraviolet and visible light are used to treat a small amount of blood, which is then reinfused.
In BT’s intravenous form, a low-intensity laser (generally at 632.8 nm) shines through a waveguide inside a needle into the blood. BT can also be administered sublingually. Continue reading »
Biophotonic Therapy uses light in an extracorporeal or intravenous mode to activate the chemiluminescence of the blood cells, a form of immunity inherited from humankind’s distant oligocellular ancestors. BT has an instructive 80-year history (see below); a range of modalities; well-characterized mechanisms of action; a wide array of indications; several counterindications; well-understood, limited side-effects in certain cases; and a scientific literature that now includes some 400 articles as well as a dozen books. No drug resistance to BT has ever been reported. Continue reading »